Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2023-03-08 00:00:00 ET · period of report 2023-03-06 · accession 0001062993-23-006325 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-08 | 2023-03-06 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale | $8.57 | -11.7K | 223.8K | -5% | -$100.7K |
| D | 2023-03-08 | 2023-03-06 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +133.0K | 235.6K | +130% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +199.5K | 199.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | S | D | 11,749 | $8.57 | 223,826 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-06 | A | A | 132,979 | $0.00 | 235,575 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-03-06 | A | A | 199,549 | $0.00 | 199,549 | D | $8.46 · — to 2033-03-06 | 199,549 Common Stock | (F2) The options vest with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |